Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
Conditions: Diabetes Mellitus; Iron Metabolism Disorders; Gastroduodenal Ulcer; Optic Atrophy; Sensorineural Hearing Loss; Platelet Dysfunction Interventions: Drug: Deferiprone; Drug: Acetylcysteine; Drug: Sitagliptin and Metformin Sponsor: Hadassah Medical Organization Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2016 Category: Research Source Type: clinical trials
Glucose Homeostasis and Incretin Effect T2DM in the Youth- a Study of the Malaysian Population
< b > Condition < /b > : Diabetes Mellitus, Type 2 < br/ > < b > Intervention < /b > : Other: OGTT and IVGTT tests < br/ > < b > Sponsors < /b > : Penang Medical College; Sarawak General Hospital; Putrajaya Hospital, Malaysia; Penang Hospital, Malaysia; Institute of Neuroscience, Padova, Italy; University of Copenhagen; Institute for Medical Research, Malaysia; Seberang Jaya Clinical Research Cent re < br/ > < b > Completed < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2016 Category: Research Source Type: clinical trials